Home/Pipeline/episil® oral liquid (SP-03)

episil® oral liquid (SP-03)

Pain associated oral mucositis

LaunchedLaunched in Japan, China, South Korea (Medical Device)

Key Facts

Indication
Pain associated oral mucositis
Phase
Launched
Status
Launched in Japan, China, South Korea (Medical Device)
Company

About Solasia Pharma K.K.

Japanese oncology-focused biopharma company developing and commercializing cancer therapeutics and supportive care products.

View full company profile

Therapeutic Areas